Table 1 Sample numbers of clinical data used from The Cancer Genome Analysis pan-cancer data set
Tumor type (TCGA ID) | Number of samples in analysis | Number of clinical parameters | |||
|---|---|---|---|---|---|
Total | Gene | micro RNA | Protein | ||
Adrenocortical carcinoma (ACC) | 92 | 75 | 80 | 46 | 5 |
Urothelial bladder cancer (BLCA) | 412 | 388 | 409 | 127 | 8 |
Breast invasive carcinoma (BRCA) | 1098 | 945 | 755 | 410 | 9 |
Cervical cancer (CESC) | 307 | 190 | 307 | 173 | 7 |
Colorectal adenocarcinoma (COADREAD) | 628 | 476 | 295 | 461 | 10 |
Esophageal cancer (ESCA) | 185 | 0 | 184 | 126 | 9 |
Glioblastoma multiforme (GBM) | 610 | 111 | 0 | 214 | 2 |
Head and neck squamous cell carcinoma (HNSC) | 528 | 496 | 486 | 212 | 9 |
Chromophobe renal cell carcinoma (KICH) | 66 | 66 | 66 | 0 | 4 |
Kidney renal clear cell carcinoma (KIRC) | 537 | 446 | 254 | 454 | 7 |
Papillary kidney carcinoma (KIRP) | 291 | 161 | 291 | 207 | 7 |
Acute myeloid leukemia (LAML) | 200 | 160 | 0 | 0 | 1 |
Lower grade glioma (LGG) | 516 | 510 | 512 | 258 | 4 |
Liver hepatocellular carcinoma (LIHC) | 377 | 189 | 372 | 0 | 7 |
Lung adenocarcinoma (LUAD) | 582 | 485 | 450 | 181 | 9 |
Lung squamous cell carcinoma (LUSC) | 504 | 178 | 342 | 195 | 8 |
Ovarian serous cystadenocarcinoma (OV) | 605 | 216 | 453 | 412 | 1 |
Pancreatic ductal adenocarcinoma (PAAD) | 185 | 145 | 178 | 106 | 9 |
Pheochromocytoma and paraganglioma (PCPG) | 179 | 161 | 179 | 79 | 1 |
Prostate adenocarcinoma (PRAD) | 498 | 419 | 494 | 0 | 4 |
Skin cutaneous melanoma (SKCM) | 470 | 290 | 351 | 169 | 6 |
Stomach adenocarcinoma (STAD) | 443 | 255 | 395 | 264 | 11 |
Thyroid carcinoma (THCA) | 503 | 397 | 502 | 222 | 7 |
Uterine corpus endometrioid carcinoma (UCEC) | 559 | 241 | 411 | 200 | 4 |
Uterine carcinosarcoma (UCS) | 57 | 56 | 56 | 48 | 1 |
Total cancer = 25 | 10,432 | 7,056 | 7,822 | 4,564 | |